1. Agnoli, A., Ruggieri, S., Falaschi, P., Mearelli, S., DelRoscio, S., D’Urso, R., and Frajes, G., 1980, Are the enkephalins involved in Parkinson’s disease? Clinical and neuroendocrine responses to naloxone administration, in: Neural Peptides and Neuronal Communication ( E. Costa and M. Trabucchi, eds.), pp. 511–521, Raven Press, New York.
2. Andrews, C. J., Neilson, P. D., and Lance, J. W., 1973, Comparison of stretch reflexes and shortening reactions in activated normal subjects with those in Parkinson’s disease, J. Neurol. Neurosurg. Psychiatry
36: 329–333.
3. Baldessarini, R. J., and Tarsy, D., 1978, Tardive dyskinesia, in: Psychopharmacology: A Generation of Progress ( M. A. Lipton, A. DiMascio, and K. F. Killam, eds.), pp. 993–1004, Raven Press, New York.
4. Berger, P. A., and Rexroth, K., 1980, Tardive dyskinesia: Clinical, biological, and pharmacological perspectives, Schizophrenia Bull. 6: 102–116.
5. Brown, E. M., Carroll, R. J., and Aurbach, G. D., 1977, Dopaminergic stimulation of cyclic AMP accumulation and parathyroid hormone release from dispersed bovine parathyroid cells, Proc. Natl. Acad. Sci. USA
74: 4210–4213.